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Background
Following my term as a regular council member (1999–2004)
and president of the annual Society for the Study of Inborn
Errors of Metabolism (SSIEM) symposium in Amsterdam,
The Netherlands, in 2004, I was elected chairman of our
society in 2004. This position was previously held by John
Walter, who ended his successful term.
Continuity on council was assured with the retention of
secretary Mick Henderson, treasurer Graham Shortland,
and the Journal of Inherited Metabolic Disease (JIMD)
chief editor Guy Besley remaining on council for at least an
additional year, and this continuity was further assured
since I understood issues and processes from my previous
years on council. Additional council members at that time
were Nenad Blau, Ubaldo Caruso, Mick Champion, Philip
Lee, Eli Anne Kvittingen, Jean-Marie Saudubray, and
Isabel Tavares de Almeida.
Mick Henderson left council in 2005 and was replaced
by Philip Lee, and Graham Shortland was replaced by
Maureen Cleary in 2006. The year 2008 was a difficult
period, with two key members leaving council. We were
saddened to hear of the serious illness that led to the
resignation of Philip Lee; we have been inspired by the way
he has fought his illness. We also had to bid a—hopefully
temporary—farewell to Maureen Cleary who moved to
Singapore and was unable to continue as treasurer.
Subsequently, Philip and Maureen were replaced by Philip
Mayne (secretary) and Jim Bonham (treasurer), both of
whom are still on council.
During my tenure as chair, we lost our valuable and
longstanding Norwegian colleague, Eli Anne Kvittingen, who
regretfully died in 2005. Other council members who left
during that time after finishing their term(s) were Ubaldo
Caruso,Mick Champion, and Jean-Marie Saudubray, and they
were subsequently replaced by Jaume Campistol, Peter
Clayton, Marjorie Dixon (as representative of the dieticians),
Jutta Gaertner, and Victor Kozich, all of whom remain on
council.
JIMD
One of the first actions of council during this time was to
appoint a successor for Guy Besley as editor-in-chief of the
journal. We invited individuals and/or groups to submit
their interest for this post, together with a business plan for
a new approach to the journal. Johannes Zschocke, Georg
Hoffmann, and Verena Peters (all based in Heidelberg,
Germany) presented a proposal that was subsequently
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chosen, and both Johannes and Georg were nominated as
editors-in-chief, with Johannes representing the JIMD in
council. Mike Gibson and Garry Brown continued as
editors: Rodney Pollitt resigned from his editorial post
after nearly 25 years. Council again expresses its deep and
lasting gratitude to both Guy and Rodney for their guiding
contributions and efforts in keeping JIMD current and
scientifically sound. Their efforts were important in
positioning the journal where it is today!
The journal format reverted to A4, and the look and
color of the front page was modernized, with a new picture
associated with a published paper on the front page of each
issue. A large group of new communicating editors was
elected to bring additional and new expertise to the review
process. The editors continued to encourage submission of
both research papers and reviews, and it seems that the
addition of further expertise and a more critical review
process resulted in an improvement in the journal’s impact
factor, which increased from 1.7 to 3.6 in these 5 years.
The new editorial board developed a strategy of making
a distinction between printed articles that are of broad
interest and solid scientific importance, compared with
online reports that—although of more limited clinical or
scientific interest—still merit documentation in the litera-
ture. This strategy has clearly been fruitful both in terms of
impact factor and in assuring an opportunity for members
of the society to have a voice in the journal. The editorial
board and council have now made this strategy a permanent
component to ensure the quality and standing of JIMD
while at the same time facilitating publication of various
articles of interest to SSIEM members. To this end,
beginning in early 2011, JIMD will have a “sister” called
JIMD Reports, which will contain all online articles. Full
details are found in the JIMD “Instructions to Authors.”
Submissions to JIMD and JIMD Reports will be un-
changed, facilitated through a single online portal. Council
recognizes the effort and diligence of the editorial team in
making these new changes and remains very supportive,
having accordingly renewed the editorial team’s tenure for
an additional 5-year period. Also, council has just complet-
ed negotiations and signed an improved and more robust
5-year contract with Springer to continue publishing both
JIMD and JIMD Reports.
SSIEM Web site
The SSIEM Web site, our portal for both the society and
others interested in inherited metabolic diseases (especially
parents and patients) was also in need of updating. This
process was started in 2005. Ubaldo Caruso and Nenad Blau
volunteered to work on this important project, and they were
supported professionally by Michael McConnell of the Black
Cat Company. Michael handles both the day-to-day Web site
activities and the electronic abstract submission and coordi-
nation during preparation for the annual symposium. Nenad
Blau remains our Web manager and is responsible for further
developments in updating and modernizing our site. We
express our continued gratitude to Michael and Nenad for this
important and long-standing effort.
Annual symposia
Our annual symposium has shown continued growth in the
number of participants from increasingly diverse countries
across the globe. A major increase occurred in 2004 in
Amsterdam, with approximately 1,000 participants, and
attendance continued to increase in Paris, France (2005);
Hamburg, Germany (2007); Lisbon, Portugal (2008); and
Istanbul, Turkey (2010); reaching more than 1,400 partic-
ipants. All of these meetings had excellent scientific
contributions and impact, in addition to attractive venues
and social activities. With strong sponsor support, these
symposia have never resulted in a deficit. I thank Jean
Marie Saudubray, Rene Santer, Kurt Ullrich, Isabel Tavares
de Almeida, and Turgay Coskun for their contributions and
responsibilities as symposia presidents and for their valued
collaboration and correspondence with council during their
respective presidential terms.
Administration
The continued growth of the SSIEM, with increasing
activities in the global inherited metabolic disease commu-
nity, has necessitated professional administrative and
secretarial support for council, directors, and trustees.
Malcolm Heron stepped down as assistant to the honorary
treasurer in December 2009 but continued to provide
valuable and ever-present consultative service during
2010. Malcolm has given tremendous support to council
and to the society membership for nearly two decades, and
we are very grateful for his ongoing efforts on our behalf.
On 1 January 2010, administrative responsibilities of
SSIEM business matters transferred to our new administra-
tive office in London, England. This office is shared with
the Association of Clinical Biochemistry (ACB) at 130–132
Tooley Street. We now have our own SSIEM business logo
and plaque on our office on the fifth floor of the Tooley
Street suite and also on the outside street door. Council
acknowledges the support that Graham Groome (now
retired), Nic Law, and their collaborators who undertook
SSIEM duties during the transition period. We are looking
forward to a long-lasting and fruitful association with our
colleagues in the ACB office.
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ETAC
Continued education and training in inherited metabolic
disease (both from the clinical and laboratory standpoint)
remains an important subject and focus for the society and for
council. The SSIEM Education and Training Advisory
Committee (ETAC) was created to advise and support SSIEM
council in all aspects of training in inherited metabolic
medicine. Paediatric Metabolic Medicine (PMM) is a recog-
nised subsection of the European Academy of Paediatrics
(EAP), which is a section of the European Union of Medical
Specialists (UEMS). Although the SSIEM has no formal role
within the European Union (EU) in developing and assessing
training for laboratory scientists, SSIEM recognizes an
important responsibility in this area. Consequently, ETAC
now comprises both clinicians and laboratory scientists from
our society. The ETAC Training and Advisory Committee is
chaired by John Walter, with Jean-Marie Saudubray as senior
advisor. Additional representatives are AndrewMorris, Vassili
Valayannopoulos, Ute Spiekerkoetter, and Shamima Rahman
with regard to clinical issues; and Brian Fowler, Mick
Henderson, Christine Vianey-Saban, and Jorgen Bierau with
regard to laboratory issues.
The responsibilities of ETAC are as follows:
& Formal assessment of clinical training centers and
programs:
National societies may apply for centers within their
country to be approved for training in PMM. This
process requires a formal written application followed
by a site visit by two members of ETAC. ETAC then
submits its recommendation to EAP. As part of the
process for training-center approval, the committee
requires information about local training programs and
trainee assessment. Syllabi are published on the SSIEM
Web site for both clinical and laboratory training.
Currently, ETAC is not responsible for assessing indi-
vidual trainees but may be in a position to provide career
guidance in the future. To date, three centers have been
approved for training: Heidelberg, Germany; Prague,
Czech Republic; and Innsbruck–Salzburg, Austria.
& SSIEM Academy:
ETAC organizes and supports the SSIEM Academy
courses for training in areas of inherited metabolic
disease. Council has allocated €50,000 for this activity
since 2008 as an annual budget to cover ETAC’s
training expenses. In 2008, a 1-day concurrent course
for both pediatricians and laboratory scientists took
place in Lisbon just prior to the start of the annual
SSIEM symposium. In October 2009, ETAC organized
a successful 2-day Academy training course in conjunc-
tion with a European Research Network for evaluation
and improvement of screening, Diagnosis, and treatment
of Inherited disorders of Metabolism (ERNDIM) meet-
ing in Basel, Switzerland; it was attended by 40
clinicians and 40 scientists, 25% of whom came from
outside Europe. ETAC is holding the next SSIEM
Academy meeting in Manchester, UK, on 4–5 October
2010, and in Amsterdam in 2011 (dates will be
announced later).
Council plans to establish an administrative office for
ETAC in Manchester in conjunction with ERNDIM, as
outlined during last year’s Annual General Meeting, and this
is now planned for 2011. Council further plans to promote a
continued expansion in training courses as part of the role of
the Academy. ETACwill undertake further accreditation visits
when requested, update the training syllabus on a regular
basis, consider whether courses in inborn errors of metabolism
are suitable for training needs—with ongoing evaluation of
these needs—and organize further specific training programs
as part of the SSIEM Academy.
ICD-11
In October 2009, the society received an invitation from
Orphanet to contribute to the revision and update of the
World Health Organization International Classification of
Diseases (ICD-11), overseen by the Topic Advisory Group
for Rare Diseases chaired by Segolene Ayme. Council
invited Dr. Guy Besley to form a working group to develop
a draft response on behalf of the society. Council acknowl-
edges the extensive work that Guy contributed to preparing
the report and agrees that if the revision steering group
decides not to adopt SSIEM’s recommended classification
in part or in full, then the society will publish the
classification on the SSIEM Web site and adopt the
classification for its own use in JIMD as well as for
training purposes.
Adult Metabolic - and Dieticians’ Groups
Regional and national interest groups continue to grow,
and council has received many enquiries from both
Europe and abroad. In follow-up to these enquiries,
council agreed to establish two special interest subgroups.
An Adult Metabolic Group (SSIEM-AMG) will be led
initially by Dr. Frederic Sedel, and a Dieticians’ Group
(SSIEM-DG) will be overseen by Dr. Reinhild Link. Both
groups are open to all members of the society, and both
will develop pages on the SSIEM Web site. Both groups
will also have the opportunity to suggest topics for the
annual meeting and will have access to and representation
on council to bring their needs into an open forum. It is
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not council’s intention to support the establishment of
disorder-related interest groups, but it was felt that both
adult metabolic inborn errors of metabolism and dietetics
warranted special expertise and additional consideration.
National societies
The society actively encourages the formation of national
societies that can communicate with each other through
SSIEM, with the goal of raising awareness to metabolic
diseases so that standards of care and research are continu-
ously improved. Corresponding members bring forward the
views of local national societies and report to council during
the annual symposium. Nominations and opinions from
corresponding members concerning SSIEM council activities
are warmly welcomed. Information about national societies
can be found on the SSIEM Web site, as can information
concerning teaching and training activities. Countries who
do not have local societies focused on inborn errors of
metabolism can seek financial and organizational support
from SSIEM, as well as guidance on educational needs and
training/educational agendas from ETAC.
ICIEM
In recent years, dialogue and collaboration has continued to
progress with the Society for Inherited Metabolic Disorders
(SIMD), the US society focused on inherited errors of
metabolism; the Australasian Society for Inborn Errors of
Metabolism (ASIEM); the Japanese Society for Inherited
Metabolic Diseases (JSIMD); and South American La
Sociedad Latinoamericana de Errores Innatos del Metabo-
lismo y Pesquisa Neonatal (SLEIMPN) under the umbrella of
the International Congress of Inborn Errors of Metabolism
(ICIEM). Recent ICIEM meetings were held in Brisbane,
Australia (2003); Tokyo, Japan (2006); and San Diego, USA
(2009). During those years, SSIEM did not hold its own
annual meeting. Council and corresponding members noted
that the opinion of SSIEM members remains quite varied
concerning the relationship between the SSIEM and the
ICIEM. It has appeared at times that a broad consensus of
discussion was absent in the decision-making process for
ICIEM meetings, and many European SSIEM members were
concerned that a European conference on inborn errors of
metabolismwas not held during the ICIEM congress years. To
improve involvement in decision making and to continue to
seek consensus where possible, a constitution was developed
for the International Organizing Committee (IOC; the
oversight council for ICIEM), and included two nominated
representatives of each society. Furthermore, the frequency of
ICIEM meetings has been changed to every 4 years instead of
3 years. The next meeting will be in Barcelona, Spain, in
2013, organized by SSIEM; and the following venue will be
Brazil in 2017. SSIEM will re-evaluate its position on ICIEM
after the 2017 meeting. Current SSIEM representatives on the
IOC are Peter Clayton and myself. I have been elected
chairman of the IOC through to the Barcelona meeting in
2013.
Personal reflections
It is remarkable that 11 years have passed so quickly during
my tenure as both a member and then chairman of council.
This decade has been a period of growth both for the
society and for me personally. There have been challenges
at times: some political, some monetary, and others
concerning interpersonal relationships. I have learned
during this time to “listen” more and work toward the best
compromises—those that benefit both my colleagues and
co-workers—but always with the needs and objectives of
the society first in my mind! The number of hours invested
(e.g., travel, meetings, discussion, paperwork) have been
too many to remember, but my main goals of seeing our
society grow—becoming ever more diverse and inclusive
each year—and having our scientific and professional
stature continue to increase, have certainly been achieved.
I hope you agree that these hours invested have been
worthwhile. Where will the future take SSIEM? Of course,
none of us know for sure, but I see an expansion of our
scientific network, more and extended advocacy for
patients with inborn errors of metabolism for whom our
members provide care, and increasing recognition of
SSIEM as a prominent component and cornerstone in the
care and support of patients with inherited metabolic
disorders. And, in the end, serving the needs of our patients
in the most comprehensive and compassionate way must
always be the primary objective for us all! My fondest
farewells to colleagues and friends as I now step aside, with
the belief that I have left the society stronger after 11 years
and certainly in the best and most competent hands.
I thank my fellow council members for all their support
and all of you as members of our society for your
confidence. It has been an honor to serve the SSIEM. My
successor is Peter Clayton from London: I wish Peter good
luck and the same support I have received.
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